We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-0.96%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$8.87B
AUM Growth
+$371M
Cap. Flow
+$510M
Cap. Flow %
5.75%
Top 10 Hldgs %
20.44%
Holding
2,307
New
202
Increased
1,106
Reduced
768
Closed
169

Sector Composition

Rank Sector Weight
1 Technology 5.47%
2 Financials 4.99%
3 Healthcare 3.94%
4 Industrials 3.75%
5 Consumer Discretionary 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XRAY icon
2226
Dentsply Sirona
XRAY
$2.31B
-11,466
Closed -$755K
XTNT icon
2227
Xtant Medical Holdings
XTNT
$44.9M
-5,357
Closed -$37K
INEQ
2228
Columbia International Equity Income ETF
INEQ
$104M
-7,117
Closed -$217K
ORKA
2229
Oruka Therapeutics
ORKA
$6.31B
-48
Closed -$14K
JOYY
2230
JOYY Inc
JOYY
$3.7B
-16,681
Closed -$1.89M
PDCO
2231
DELISTED
Patterson Companies, Inc.
PDCO
-5,869
Closed -$212K
MFD
2232
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
-20,084
Closed -$250K
ASXC
2233
DELISTED
Asensus Surgical, Inc.
ASXC
-771
Closed -$19K
MCBC
2234
DELISTED
Macatawa Bank Corp
MCBC
-10,254
Closed -$103K
FEN
2235
DELISTED
First Trust Energy Income and Growth Fund
FEN
-7,697
Closed -$204K
NS
2236
DELISTED
NuStar Energy L.P.
NS
-6,862
Closed -$206K
MDC
2237
DELISTED
M.D.C. Holdings, Inc.
MDC
-8,435
Closed -$231K
HTY
2238
DELISTED
JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND
HTY
-13,296
Closed -$117K
EDI
2239
DELISTED
Virtus Stone Harbor Emerging Markets Total Income Fund
EDI
-45,350
Closed -$706K
AIMC
2240
DELISTED
Altra Industrial Motion Corp
AIMC
-4,018
Closed -$203K
CLR
2241
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-8,157
Closed -$432K
SHLX
2242
DELISTED
Shell Midstream Partners, L.P.
SHLX
-9,183
Closed -$274K
SRRA
2243
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-967
Closed -$144K
PVG
2244
DELISTED
PRETIUM RESOURCES INC.
PVG
-14,303
Closed -$163K
COR
2245
DELISTED
Coresite Realty Corporation
COR
-3,547
Closed -$404K
USCR
2246
DELISTED
U S Concrete, Inc.
USCR
-3,723
Closed -$311K
PRAH
2247
DELISTED
PRA Health Sciences, Inc.
PRAH
-18,652
Closed -$1.7M
GLOG
2248
DELISTED
GASLOG LTD
GLOG
-9,300
Closed -$207K
MIK
2249
DELISTED
Michaels Stores, Inc
MIK
-8,994
Closed -$218K
IBDL
2250
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
-8,903
Closed -$225K

Similar funds

Cambridge Investment Research Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Cambridge Investment Research Advisors held 2,307 positions worth $8.87B, up 4.4% from $8.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $510M of net new capital in Q1 2018, opening 202 new positions and adding to 1,106 existing holdings. Its largest new stake was BrightSpire Capital: 489,150 shares worth $9.27M.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 5.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $24.6M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2018 buy was BrightSpire Capital: 489,150 shares worth $9.27M.
  • Cambridge Investment Research Advisors added most to iShares S&P Mid-Cap 400 Growth ETF in Q1 2018, an estimated $21.9M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $24.6M.
  • Cambridge Investment Research Advisors fully exited KB Financial Group in Q1 2018, selling an estimated $3.4M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $8.87B portfolio in Q1 2018.
  • Cambridge Investment Research Advisors opened 202 new positions and closed 169 in Q1 2018.
  • Cambridge Investment Research Advisors's portfolio value rose 4.4% quarter-over-quarter to $8.87B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.